[/caption]Carol Forsloff - New research reported by Diabetes magazine reports that an oral or nasal administration of insulin can protect against the development of Type I diabetes.
52 adults were tested over a period of 12 months, some given a placebo and others nasal insulin. The results showed that the nasal spray provided protection against the development of Type I by inducing an immune tolerance to insulin.
Gizmag quotes Professor Len Harrison of the Walter and Eliza Hall Institute in Melbourne, Australia as saying, "The results showed that the vaccine allowed the immune system to restore immune tolerance to insulin. When subsequently given insulin by injection, the participants who had received the nasal insulin vaccine were found to be desensitized to insulin."
According to the American Diabetes Association Type I diabetes is an early onset disease diagnosed in children and young adults and that is characterized by the body’s inability to produce insulin. Insulin is a hormone required for sugar conversion and turning it into the kind of energy the body needs to live healthy life.
Those people who have early onset diabetes require lifelong insulin treatments, so this new research is considered a major breakthrough in prevention of the disease.
